Single dose of subcutaneous tocilizumab in COVID-pneumonia: CT evidence of lymph nodal and parenchymal response

J Med Virol. 2021 Feb;93(2):599-600. doi: 10.1002/jmv.26345. Epub 2020 Aug 13.

Authors

Antonio Vizzuso¹, Sara Piciucchi¹, Daniela Tortola², Carmela Grosso³, Claudia Ravaglia⁴, Venerino Poletti^{4

5}

Affiliations

¹ Department of Radiology, Ospedale GB Morgagni, Forlì, Italy.
² Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
³ Department of Infective Diseases, Ospedale GB Morgagni, Forlì, Italy.
⁴ Department of Diseases of the Thorax, Ospedale GB Morgagni, Forlì, Italy.
⁵ Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.

PMID: 32716066
DOI: 10.1002/jmv.26345

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage*
COVID-19 / diagnosis
COVID-19 Drug Treatment*
Humans
Injections, Subcutaneous
Lung / diagnostic imaging*
Lung / pathology
Lymph Nodes / diagnostic imaging*
Lymph Nodes / pathology
Male
Middle Aged
Parenchymal Tissue / pathology
Tomography, X-Ray Computed
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
tocilizumab